Skip to main content

Endovascular Engineering

Menlo Park, United States

Endovascular Engineering develops and deploys advanced clot removal solutions for the treatment of venous thromboembolism.

$80.0M raised
Apr 2026
Series C

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Endovascular Engineering

How much funding has Endovascular Engineering raised?
Endovascular Engineering has raised $80.0M in total funding. The most recent round was Series C. The last funding was announced in April 2026.
Who are Endovascular Engineering's investors?
Endovascular Engineering's investors include Norwest, S3 Ventures, Sante Ventures, Panakes Partners, Gilde Healthcare.
Where is Endovascular Engineering headquartered?
Endovascular Engineering is headquartered in Menlo Park, United States.
What does Endovascular Engineering do?
Endovascular Engineering develops and deploys advanced clot removal solutions for the treatment of venous thromboembolism.
What stage is Endovascular Engineering at?
Endovascular Engineering is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Endovascular Engineering — Funding & Investors." VCBacked, April 7, 2026, https://www.vcbacked.co/company/endovascular-engineering. Accessed July 2, 2026.
APA
VCBacked. (2026). Endovascular Engineering — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/endovascular-engineering
Wikipedia (cite web)
{{cite web |title=Endovascular Engineering — Funding & Investors |url=https://www.vcbacked.co/company/endovascular-engineering |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .